Clinical Trial Update: Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating adjunctive ganaxolone for PCDH19-related epilepsy in female children has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Protocadherin 19-related Epilepsy

Drugs mentioned

• ganaxolone (ganaxolone)

Snippet

Sponsor: Marinus Pharmaceuticals | Conditions: PCDH19-Related Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2022-09-08